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Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MarylandABSTRACT We report for the first time, to our knowledge, that the N-terminal loop (N_loop) of amylin (islet amyloid polypeptide
(IAPP) residues 1–8) forms extremely long and stable non-b-sheet fibers in solution under the same conditions in which human
amylin (hIAPP) forms amyloid fibers. This observation applies to the cyclic, oxidized form of the N_loop but not to the linear,
reduced form, which does not form fibers. Our findings indicate a potential role of direct N_loop-N_loop interactions in hIAPP
aggregation, which has not been previously explored, with important implications for the mechanism of hIAPP amyloid fiber for-
mation, the inhibitory action of IAPP variants, and the competition between ordered and disordered aggregation in peptides of
the calcitonin peptide family.INTRODUCTIONIslet amyloid polypeptide (IAPP), also known as amylin, is a
37-residue intrinsically disordered hormone peptide that is
secreted together with insulin by the b cells of the pancreas
and is involved in glucose regulation and gastric emptying
(1–4). IAPP is implicated in the pathogenesis of diabetes
type II due to its deposition in the form of amyloid fibers
in the b cells of the pancreas, where insulin is produced
(5). It is a member of the calcitonin peptide family (6),
which includes calcitonin (Ct), calcitonin-gene-related pep-
tide (CGRP), adrenomedullin (Ad), intermedin, and amylin.
These are structurally and genetically related intrinsically
disordered hormone peptides, with sequence homology
ranging between 20% and 50% (7). All members of the Ct
family contain a functional disulfide bond that confers a
short ringlike structure (N_loop) to the N-terminus of the
peptide (with the exception of Ad, in which the disulfide
is located between residues 16 and 21). The sequence of
the N_loop is highly conserved among Ct family members.
Although some members of this family are prone to
aggregate, others are remarkably soluble. A similarly dra-
matic difference is also manifest among variants of individ-
ual Ct family members. For example, human IAPP (hIAPP)
readily forms amyloid fibrils in vitro, whereas the rat variant
(rIAPP), differing by six amino acids, does not (Fig. 1)(8).
In addition to being highly soluble, rIAPP is an effective
inhibitor of hIAPP fibril formation (9). Both these properties
of rIAPP have been attributed to the presence of three
b-breaking prolines located in the C-terminal half of the
peptide (10,11). It has been recently shown that rIAPP inter-Submitted May 3, 2013, and accepted for publication August 21, 2013.
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0006-3495/13/10/1661/9 $2.00acts with hIAPP during fibril formation through its N-termi-
nal region (12). Although the nature of such an interaction,
which does not involve b-sheet formation, has not been
identified, association of a-helical intermediates had origi-
nally been proposed (9). According to the most recent
structural model of hIAPP fibrils, derived from two-dimen-
sional-NMR (2D-NMR) restraints, monomers are aligned at
the N-terminus and form in-register parallel b-sheets (13).
In this structure, the N_loop is not involved in direct inter-
molecular interactions. Removal of the N_loop, however,
alters both the mass/length distributions of hIAPP fibers
(14) and the kinetics of fibril formation, with effects that
vary with experimental conditions (15,16).
The mechanism by which the N_loop affects hIAPP
aggregation is not yet understood, but it is important for
rationalizing the kinetics and potentially developing inhibi-
tors (17,18). The leading hypothesis is that the N_loop alters
hIAPP aggregation kinetics indirectly, by affecting the
conformational preferences of the monomer in solution
(15,16,19). For example, ring opening of the N_loop by
chemical reduction decreases the helical content of rIAPP
(assumed to be a good structural model of hIAPP) (19,20),
and the N_loop has been shown to induce the collapse of
rIAPP, hIAPP, and a model hydrophilic peptide (21). Molec-
ular simulations indicate that the N_loop has a rigid struc-
ture, suggesting that it may act as a nucleus driving
compaction (21). However, a direct role of the N_loop in
the aggregation of hIAPP, and in the inhibition of hIAPP
by rIAPP, has not yet been explored. The findings presented
here indicate that direct association of the N_loop alone is a
favorable process at micromolar concentrations.METHODS
Materials
9-Fluorenylmethoxycarbonyl (Fmoc)-protected amino acidswere purchased
from Novabiochem (Bubendorf, Switzerland). N-hydroxy benzotriazolehttp://dx.doi.org/10.1016/j.bpj.2013.08.026
FIGURE 1 Sequences of human IAPP (hIAPP), rat IAPP (rIAPP), and
N_loop. The disulfide bond between residues 2 and 7, forming a loop at
the N-terminus of the sequences, is indicated by the blue brackets. All
sequences have a free N-terminus and amidated C terminus. To see this
figure in color, go online.
1662 Cope et al.(HOBt) and O-Benzotriazole-N,N,N0,N0-tetramethyl-uronium-hexafluoro-
phosphate (HBTU) were purchased from Genscript. N,N-iisopropylethyl-
amine, or Hu¨nig’s base (DIPEA), and N-Methyl-2-pyrrolidone (NMP),
used as a base in solid-phase peptide synthesis, were purchased from Sigma
Aldrich (St. Louis, MO). Piperidine (Sigma-Aldrich) was used for deprotec-
tion. Rink Amide ChemMatrix was purchased from Matrixx Initiatives
(Scottsdale, AZ). Dimethyl formamide (DMF), dichloromethane (DCM),
and acetonitrile were purchased from Fisher Scientific (Waltham, MA) and
were used without further purification.Peptide synthesis and purification
N1–8 was synthesized on a 0.25 mmol scale using a CEM (Cambridge,
MA) Liberty automated microwave peptide synthesizer and PALChem
(Angres, France) matrix resin. After synthesis, the peptide was thoroughly
washed five times with DMF followed by DCM. After washing, the peptide
was stored on the resin at 20C. For deprotection, the peptide was shaken
for 1 h in 20% piperdine, 0.1 M HOBt in DMF. The cleavage cocktail con-
sisted of 95% trifluoroacetic acid (TFA)þ 2.5% waterþ 2.5% triisopropyl-
silane (TIS) at a ratio of 150 mL/10 mg resin. N1–8 was purified using
reverse-phase high-performance liquid chromatography (HPLC) on a
Waters 600E system. Crude peptide was purified on a C18 semi-preparative
column (Vydac/Grace, Deerfield, IL) at a gradient of 0–14% acetonitrile
with 0.1% (v/v) TFA over 45 min.Disulfide formation and oxidized peptide
purification
Lyophilized peptide (1.0 mM) was dissolved in 30% dimethylsulfoxide
(DMSO) and 3% acetic acid. The sample was stirred with a magnetic stir
bar at 1100 rpm. During this time, the formation of the intramolecular
disulfide bonds was monitored via HPLC on a C18 analytical column.
The reaction was deemed complete when the reduced peptide’s HPLC
peak was no longer apparent: ~10 h. After this time, the sample was frozen
and lyophilized. Oxidized peptide was repurified on a C18 semipreparative
column to separate any unreacted peptide.
Calibrated matrix-assisted laser-desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) indicated the presence of a 2 Da
species (above the margin of error of the instrument), corresponding to
the oxidized form of the peptide, N_loop. To further support these findings,
a maleimide sulfhydryl reaction was performed.Three-(N-maleimidopro-
pionyl)-biocytin (Cayman Chemical, Ann Arbor, MI) (1 mg) was dissolved
in 180 mL 20 mM phosphate-buffered saline (PBS), pH 7.0, and 20 mL
acetonitrile. Pure, oxidized N_loop (1 mg) was dissolved in 90 mL
20 mM PBS buffer, pH 7.0, and 10 mL acetonitrile. This solution was com-
bined with the 3-(N-maleimidopropionyl)-biocytin solution and shaken for
4 h. At 1 h increments, 20 mL aliquot was removed and frozen in dry ice.
After 4 h, the four aliquots were analyzed via MALDI-TOF MS.
HPLC peaks were analyzed by a Voyager Systems 4320 MALDI-TOF
MS (Applied Biosystems, Foster City, CA). The peak corresponding to a
molecular weight of 807 Da (corresponding to the amidated and oxidized
form of the peptide) was analyzed further for purity by analytical HPLC,Biophysical Journal 105(7) 1661–1669using a reverse-phase C18 analytical column 214TP54 (length 250 mm 
inner diameter (ID) 4.6 mm, particle size 5 mm) using the same gradient
conditions with a 0.9 mL/min flow rate. A single peak eluting at a gradient
corresponding to the hydrophobicity of N_loop was collected, immediately
frozen in liquid nitrogen, lyophilized, and kept at 20C.Fiber preparation
For each measurement, solutions of N_loop were prepared fresh at T ¼
23C. The N1–8 samples were prepared in deoxygenated conditions and
in the presence of a two-time molar excess of tris(2-carboxyethyl)phos-
phine hydrochloride (Sigma Aldrich). Buffer was 50 mM sodium acetate
at pH 4.9. After adding the buffer to lyophilized peptide in a glass vial, sam-
ples were stirred with a glass stirring rod until all peptide was dissolved.
The concentration of peptide was measured by absorbance at 205 nm, using
an extinction coefficient of ε ¼ 11,040 M1 cm1. This was obtained from
the linear dependence of absorbance versus concentration measured for
solutions of N1–8 in the 60–200 mM range (solutions were prepared by
direct dilution from a 200 mM stock solution).Circular dichroism
Circular dichroism (CD) spectra of the samples were measured in quartz
cuvettes (Starna Cells, Atascadero, CA) ranging in pathlength from 10 to
0.1 mm. Stock solutions were diluted with Millipore (Billerica, MA)
H2O, resulting in final buffer concentrations ranging from 10 to 25 mM
NaAc. A J-710 spectropolarimeter (Jasco, Oklahoma City, OK) was used
with a 1 nm bandwidth. For each sample, eight spectra taken with a
0.2 nm pitch at a 50 nm/min scan speed were averaged. Before data anal-
ysis, spectra were buffer-subtracted.Transmission electron microscopy
Carbon Type B (15–25 nm) 200mesh grids with Formvar coating (Ted Pella,
Redding, CA) were glow-discharged using a plasma cleaner immediately
before applying the sample. The N_loop sample was diluted to a final con-
centration of 7–25mM and allowed to adsorb to the grid for 5 min. The sam-
ple was blotted and rinsed with Millipore water using No. 1 Whatman filter
paper. Immediately after blotting, 5 mL of freshly filtered 1% uranyl acetate
was applied for 2 min, then blotted. Grids were imaged on a Philips CM 12
scanning transmission electron microscope (TEM), operated at 80 kV.Thioflavin-T assay
Thioflavin-T (ThT) binding assays were used to detect the presence of
amyloid fibrils within N_loop samples. Final solutions contained 10 mM
ThT, 12.5 mM KCNTATCA in 50 mM sodium acetate, pH 4.9. All ThT
experiments were conducted in a QuantaMaster 40 (Photon Technology
International, Birmingham, NJ). Emission spectra were monitored at exci-
tation wavelengths of 350 nm and 450 nm, whereas excitation spectra were
monitored at emission wavelengths of 450 nm and 480 nm. Excitation and
emission slits were kept at 2 nm. ThTwas purchased from Pierce, Thermo
Fisher Scientific (Rockford, IL).Fourier transform infrared spectroscopy
N_loop fiber solutions were lyophilized after aging for 1 week at 4C.
Monomeric N_loop samples were lyophilized immediately after HPLC
purification. To minimize the possibility of aggregates forming during the
lyophilization process, small fractions corresponding to pure N_loop
were instantly frozen in liquid nitrogen and maintained in the solid (frozen)
phase during the entire lyophilization process. HPLC analysis of samples
Fibers from N-Terminal Loop of Amylin 1663pre- and postlyophilization show conservation of mass. This observation
supports the lack of insoluble aggregate formation during lyophilization.
Lyophilized peptide was mixed with oven-dried KBr using a mortar and
pestle. The sample was further dried under vacuum for 1 min, and pressed
into a pellet. Fourier transform infrared (FTIR) spectra were recorded on a
Vertex 70 series instrument (Bruker, Billerica, MA). The optical chamber
was flushed with nitrogen for 15 min before each scan. The interferograms
were averaged over 512 scans with a resolution of 1 cm1. Atmospheric
compensation (for residual H2O vapor and CO2) and baseline correction
(using 10 iterations of concave rubberband correction) were performed us-
ing Opus V6.5 software. Control KBr spectra were subtracted from peptide
spectra. In the data shown, the fiber absorbance value was rescaled by a con-
stant such that the magnitude of the amide I band matched the absorbance
value for the monomer pellet.Optical microscopy
All imaging was performed on a BH2-UMA optical microscope (Olympus,
Center Valley, PA). A quarter waveplate was aligned to 45 for birefrin-
gence imaging. All measurements were made at 10 magnification.NMR spectroscopy
Lyophilized peptide was dissolved in 100% deuterated DMSO (Cambridge
Isotopes, Andover, MA) for a final peptide concentration of 1.3 mM. All
spectra were acquired at 25C on a 500 MHz Varian (Palo Alto, CA) spec-
trometer. One-dimensional NMR spectra of N_loop were recorded before
each experiment and did not change, indicating that no significant confor-
mational change or aggregation occurred for the duration of the experi-
ments. Spectra were calibrated to the residual solvent peak for DMSO,
2.49 ppm. Two-dimensional COSY and TOCSY spectra were recorded
using a mixing time of 100 ms. 1H chemical shifts determined from the
TOCSY spectrum are reported in the Table S1 of the Supporting Material
together with the nuclear Overhauser effect (NOE) spectra (Figs. S7 and
S8). Secondary chemical shifts, used to identify secondary and residual
structure in intrinsically disordered proteins (22), were calculated by sub-
tracting reference random-coil values from De Simone et al. (23) from
our measured chemical shifts. Comparison with alternative random-coil
libraries (23–25) is reported in Fig. S3. Two-dimensional NOE spectroscopy
(NOESY) experiments were measured for both 400 ms and 80 ms mixing
times. NOEs were exported from VNMRJ (Varian) and further analyzed
in CARA (Keller, Rochus, The Computer Aided Resonance Assignment
Tutorial). NOE peak volumes were converted into relative strengths by cal-
ibrating them to the crosspeak of the two 1Hb protons of cysteine 2, assumed
to be at a fixed distance of 1.8 A˚. NOE strengths were classified into weak
(<4.0 A˚), medium (<3.3 A˚), and strong (<2.6 A˚) using cutoffs from Nilges
and co-workers (26). Additional NOE data are shown in Fig. S9.FIGURE 2 (a) Oxidized N_loop fibers, visible immediately upon dissolv-
ing peptide in buffer (50 mM peptide in 50 mM sodium acetate, pH 4.9).
Immediate formation of fibers was also observed at concentrations of
57 mM by TEM (Fig. S1). (b) Optical microscopy of N_loop fibers in the
absence (left) and presence (right) of crossed polarizers, revealing fiber bire-
fringence (scale bar, 1 mm). (c) TEM image of fibers prepared at 25 mM
(scale bar, 200 nm). Fibers of samemorphologywere observed at concentra-
tions as low as 57 mM (Fig. S1). To see this figure in color, go online.Molecular dynamics simulations
Replica-exchange molecular dynamics (REMD) simulations of the amylin
monomer were carried out in explicit TIP3P water, with the Amber ff03*
force field for the protein and ions (27). Periodic boundary conditions
with a 3.5 nm truncated octahedron cell containing the peptide and 1033
water molecules, four sodium, and six chloride ions, were used. Long-range
electrostatic interactions were computed using particle mesh Ewald with a
real-space cutoff of 0.9 nm and a grid spacing of 0.1 nm. All bond lengths
were constrained to their reference values using the LINCS algorithm. This
system was equilibrated at constant pressure and a temperature of 295 K,
using a Parrinello-Rahman Barostat and Langevin thermostat with a friction
coefficient of 1 ps1 for 200 ps, with an integration time step of 2 fs. After
the equilibration, REMD simulations were performed at constant volume,
with 32 replicas spanning a temperature range from 278 to 595 K, using
a Langevin thermostat to control the temperature of each replica, andwith exchange attempts every 2 ps. Structures from the 295 K replica
were clustered using the g_cluster utility with the single-linkage method
and a cutoff of 0.08 nm. Additional REMD simulations of a pair of amylin
monomers were performed using the same simulation parameters, and all
structures forming direct contacts (defined as a minimum atom-atom dis-
tance between monomers of <0.2 nm) were analyzed.RESULTS
N_loop fiber formation
We set out to investigate the properties of the isolatedN_loop
(residues 1–8 of hIAPP) in the oxidized and reduced form.
We prepared the linear, reduced form of hIAPP1–8 (N1–8)
by solid-phase peptide synthesis. We obtained the oxidized,
cyclic form (N_loop) by oxidation in DMSO of N1–8 fol-
lowed by purification and lyophilization (see Methods).
Remarkably, we found that the cyclic peptide immediately
forms fibers visible by eye when dissolved in aqueous buffer
at peptide concentrations ranging from 0.65 mM to 50 mM
(Fig. 2 a) By contrast, the linear peptide N1–8 did not form
fibers under the same experimental conditions. Light micro-
scopy imaging of the fibers reveals strong birefringence
( Fig. 2 b), indicating a large degree of supramolecular
ordering in the fibers. Consistently, TEM images show large
bundles of aligned microfibers ( Fig. 2 c). Fibers of the same
morphology where observed in TEM within 1 h of sample
preparation, at concentrations as low as 57 mM (Fig. S1).
Fibers did not appear to dissolve under highly acidic condi-
tions (pH <2) or after heating to 80C. Based on a ThTBiophysical Journal 105(7) 1661–1669
1664 Cope et al.binding assay, the fibers do not appear to be amyloid in nature
(28) (Fig. S2). This is further confirmed by the absence of b-
sheet features in both CD and FTIR spectra presented below.
The sequence of N_loop (Fig. 1) does not contain partic-
ularly hydrophobic or insoluble side chains that would
suggest such aggregation. We therefore hypothesize that
structural features associated with peptide cyclization are
conducive to fibril formation. To investigate such features,
we analyzed the linear and cyclic monomer as well as the
fibers, using CD and FTIR spectroscopy (Fig. 3).
The CD spectrum of the linear peptide ( Fig. 3 a) is typical
of linear disordered coils (29). In contrast, the spectrum of the
cyclic peptide deviates significantly from disordered coils
and contains distinct features. We compared it to the pure-
component spectra obtained by spectral deconvolution of
model cyclic peptides of similar length, inwhich the structure
was determined by x-ray crystallography and solution NMR
(30), (31). Fig. 3 a shows the overlay of the type II (blue line)
and type I b-turn spectrum (black dotted line) (30) with the
N_loop spectrum (black line). The resemblance with the
type Ib-turn spectrum is striking, considering that in short cy-
clic peptides CD is sensitive to very small backbone confor-FIGURE 3 (a) CD spectra of linear N1–8 (gray line) and cyclic N_loop (blac
coil (dotted gray line), type I b-turn (dotted black line), and type II b-turn (dotte
ellipticity. (b) Temperature dependence of CD spectra from 5C to 70C of N_lo
Concentration dependence of N_loop CD signal amplitude at minimum, ε, res
spectra do not vary with concentration (inset) (20C, pH 4.9 in 10–25 mM s
N_loop peptide (gray) versus fibers (red) in the amide region. N_loop samples w
were lyophilized after 1 week aging at 4C (7 mM peptide in 50 mMNaAc, pH 4.
given for the N_loop spectrum. The vertical gray line indicates the characteristic
sated, baseline corrected, and KBr subtracted. To see this figure in color, go on
Biophysical Journal 105(7) 1661–1669mational distortions (31). We therefore attribute the CD
spectral features of cyclic N_loop to a type I b-turn structure.
We derived further information on the structural rigidity
of the peptides by monitoring the change in CD spectra as
a function of temperature (Fig. 3 b). Although the spectrum
of N1–8 displays significant changes upon increasing tem-
perature, consistent with a noncooperative loss of polypro-
line II structure (as observed in other disordered proteins
(32,33)), the N_loop remains almost unchanged. We
conclude that cyclization imparts rigidity to the N_loop,
rendering the type I b-turn stable to thermal denaturation.
To gain insight into the structural changes occurring upon
fiber formation, we measured the CD spectra as a function
of peptide concentration in the 10 mM to 12 mM range,
which includes concentrations at which fibers were clearly
visible. To our surprise, the signal amplitude followed a sim-
ple linear dependence with concentration (Fig. 3 c) and we
observed no spectral changes (Fig. 3 c, inset). By contrast,
significant spectral changes are typically observed during
amyloid fibril formation, as peptides convert from disor-
dered structures to b-sheet structures. Two explanations
are possible: either the N-loop monomer does not changek line) peptides at 5C compared to pure component spectra for disordered
d blue line) (redrawn from Perczel and Fassman (30)); MRE, mean residue
op and N1–8 (inset) (660 mM peptide in 50 mM sodium acetate, pH 4.9). (c)
caled by pathlength l (solid circles) and linear fit (line); renormalized CD
odium acetate buffer). (d) FTIR spectra of KBr pellets of HPLC-purified
ere lyophilized immediately after HPLC purification. N_loop fiber samples
9). Peak positions for the amide I (1675 cm1) and II (1533 cm1) bands are
amide I peak of IAPP amyloid fibrils. All spectra are atmospheric compen-
line.
Fibers from N-Terminal Loop of Amylin 1665conformation upon aggregation or the fibers do not
contribute to the CD signal. In the latter case, we would
expect to observe a saturation of the signal amplitude at
increasing peptide concentrations, as the monomers
approach the solubility limit. The linear dependence of the
signal at concentrations beyond those needed for fiber for-
mation suggests instead that the monomer structure does
not change upon fiber formation, and that the fiber structure
does not introduce appreciable supramolecular chirality.
There remains a third possibility, that even at 10 mM, the
N_loop is present as a very low-molecular-weight oligomer
(dimer/trimer/...) rather than as a monomer. In this event,
our results would mean that the N_loop monomer has the
same conformation in the low-molecular-weight oligomers
(rather than monomers) and in the fibers. The question is
then whether the structure of the monomer would be
much affected by the formation of oligomers. Further evi-
dence from REMD simulations, provided below, supports
the contention that the monomer structure is rigid and is
not significantly affected by aggregation.
To further test these conclusions, we compared the FTIR
spectra of the HPLC purified peptide with those of the fibers
in the amide region (Fig. 3 d). The appearance of fine struc-
ture in the fiber spectrum (red) indicates quasicrystalline
order in the fibers. These data confirm the high degree of
microscopic order revealed by birefringence (Fig. 2 b).
Further, the observed increase in intensity of the near-
amide-III bands (1300–1500 cm1), which reflects contribu-
tions from methylene (CH2) and methyl (CH3) bending
vibrations of aliphatic side chains (34), is consistent with
packing of these side chains within the fibers. In contrast,
the positions of the amide I and II peaks, which reflect back-
bone secondary structure (35), do not change. Thus, there is
no significant backbone structural rearrangement when the
N_loop is incorporated into the fibrils. The FTIR spectrum
also confirms the absence of b-sheet structures in the
fibers, which would appear as a distinct amide I peak at
1620–1630 cm1 (36–38). The position of the amide I
peak at 1675 cm1 is consistent with a b-turn structure
(observed in model linear and cyclic b-turn peptides at
1672–1674 cm1) (39–42), in agreement with our interpre-
tation of the CD spectrum of the N_loop (Fig. 3a).Taken
together, the data presented here indicate that the disulfide
bond constrains the N_loop into a fairly rigid, well defined
structure containing a type I b-turn. This structure highly
favors the formation of stable interpeptide interactions that
result in the observed formation of fibers.FIGURE 4 Comparison of secondary chemical shifts measured for
N_loop (green), using random coil values of reference De Simone et al.
(23), and values reported in Yonemoto et al. (16) and Williamson and Mir-
anker (43), for residues 1–8 of full-length hIAPP (red) and rIAPP (blue).
Values computed from REMD simulations using SPARTAþ (black) are
also compared with experimental data sets. Error bars on the calculated
shifts represent the root mean-squared error in the shift prediction algo-
rithm. To see this figure in color, go online.Solution NMR
To obtain more detailed structural information on the
N_loop, we measured proton chemical shifts and NOEs
by 2D-NMR solution spectroscopy. Given the low solubility
of N_loop in aqueous solvent, we performed these measure-
ments in 100% deuterated DMSO. We calculated protonsecondary chemical shifts by subtracting residue-specific
random-coil values (23) from our measured chemical shifts.
These values are typically used to identify propensities to
populate a-helix versus b-sheet dihedral angles in intrinsi-
cally disordered proteins (22). Fig. 4 shows a comparison
between values obtained here for N_loop and values previ-
ously reported by Yonemoto et al. (16) and Williamson et al.
(43) for the corresponding residues of full-length hIAPP and
rIAPP, respectively. These data do not indicate significant
structural differences between the N_loop and the corre-
sponding residues of full-length IAPP, considering the dif-
ference in solvent conditions and the variations originating
from the use of different random-coil libraries (a compari-
son of random-coil libraries (23–25) is shown in Fig. S3).
In the Supporting Material, we also consider the effect of
aqueous dilutions of DMSO (Figs. S4 and S5).
In Table 1, we report the strength of amide-amide sequen-
tial NOEs obtained from 2D-NOESY experiments, which
we have classified as weak, medium, and strong, according
to cutoffs reported byNilges et al. (26) (additional NOE data
are shown in Fig. S9). As an internal calibration standard,
we used the known distance (1.8 A˚) between the two b-pro-
tons of C2. Analysis of the 80 ms and 400 ms mixing-time
spectra yielded similar results (Fig. S9). We note that
direct comparison between these values and those reported
by Yonemoto et al. would require the use of robust and
self-consistent internal calibration standards. Generally
speaking, though, our NOE peaks are consistent with those
observed by Yonemoto et al. (16), with the exception of the
presence of a T4-A5 crosspeak (absent in the Yonemoto
study (16)), which appears instead of the T4-A8 crosspeak
observed by Yonemoto and co-workers (16). The proximity
of T4 and A8 observed in the Yonemoto work (16) was
attributed to a stabilizing effect that the N_loop would
have on the helical conformational ensemble sampled by
residues 8–18 of full-length hIAPP. The absence of the
T4-A8 crosspeak in the N_loop, where residues 9–37 areBiophysical Journal 105(7) 1661–1669
TABLE 1 Comparison between measured NOEs and
distances from simulations
Residues NOE Simulation distance (A˚)
1 and 2 Medium 4.05
2 and 3 Medium 4.44
3 and 4 Strong 3.03
4 and 5 Medium 3.13
5 and 6 Strong 2.73
6 and 7 Strong 2.40
7 and 8 Strong 2.88
Amide-amide sequential NOE strengths and averaged distances computed
as <r3>1/3 from the REMD simulation replica at 295 K. Additional
NOEs and comparison to simulations are shown in Fig. S9.
FIGURE 5 Structure of N_loop from molecular simulations in CPK rep-
resentation. (a) Most populated conformation (64.0%), with type I turn
between residues 3 and 6. (b) Next-most populated conformation
(33.3%), with type I turn between residues 4 and 7. To see this figure in
color, go online.
1666 Cope et al.missing, is consistent with this interpretation. In summary,
these data do not indicate significant backbone structural
changes between the isolated N_loop and the corresponding
residues of full-length hIAPP. Although this is not generally
expected for linear fragments of full-length proteins, it is not
surprising in the case of short, relatively rigid cyclic pep-
tides such as the N_loop.MD simulations
To provide a molecular description of the possible location
of the type I b-turn in the N_loop monomer, we ran
REMD simulations of the N_loop sequence studied here
(residues 1–8). The N_loop conformations we obtained are
similar to those found in our earlier work (21). Because of
the constraint introduced by the linker, the N_loop only
adopts a limited number of backbone conformations. This
rigidity is evident in the Ca root mean-square fluctuations
of the backbone, which are only 1.0 A˚ at 278 K, and increase
to 1.15 A˚ at the highest REMD temperature of 595 K.
Conformational clustering with a 0.8 A˚ cut-off yields two
major conformations with populations of 64.0% and
33.3%, with the remaining conformations having very low
populations. Secondary-structure assignment using STRIDE
indicates that the most populated cluster (Fig. 5 a) has a type
I turn between residues 3 and 6 and a type IV turn between
residues 4 and 7, whereas the second-most-populated cluster
(Fig. 5 b) has a type I turn from residues 4 to 7. Thus, there is
expected to be a large population of type I turns, consistent
with the experimental findings. Type I b-turns are geometri-
cally defined as a stretch of four residues (i,iþ 3), with a car-
bons of residues i and i þ 3 within 7 A˚ and internal residues
i þ 1 and i þ 2 having (j,f) angles of (30,60) and
(0,90), respectively (44). We found, based on these geo-
metric criteria (Fig. S6), that a type I b-turn is present at
residues 3–6 most of the time, with a significant fraction of
type I turn also present at residues 4–7, in agreement with
the analysis of the most populated clusters. We have also
validated the results of the simulations by comparison with
the available NMR data. Calculation of average 1Ha and
1HN chemical shifts using the SPARTAþ shift prediction
algorithm (45) results in reasonable agreement with experi-Biophysical Journal 105(7) 1661–1669mental data from several groups, including our own, consid-
ering the uncertainty in the shift prediction (Fig. 4). We find
that 75% of the predictions lie within the (one-standard-de-
viation) error bars for the HN shifts and 63% for the Ha shifts.
The linear correlation coefficients are 0.84 and 0.1 for the HN
and Ha shifts, respectively. Furthermore, the distances
between amide protons measured in the simulation correlate
well with the intensities of the NOEs measured for the
N_loop (Table 1 and Fig. S9).
To investigate how much the structure of the monomer
might be affected by self-association, we performed
REMD simulations of a pair of monomers at ~100 mM con-
centration and analyzed the configurations where the two
molecules are in direct contact. The structures of the mono-
mers in the associated configurations were generally very
similar to those of the isolated peptides, with 70% of the
monomers having a Ca root mean-square deviation from
the central structure of the largest cluster of the monomer
simulations of <1.0 A˚. Representative clusters of the asso-
ciated pairs of monomers are given in Fig. S10. These
results also shed some light on the type of interactions
that may drive aggregation—the peptides associate through
a variety of polar interactions but clearly not through a clas-
sical amyloid structure. Although there are certainly some
intermolecular interactions involving the backbone, because
the amide groups are not aligned in the same direction, con-
ventional amyloid structure is not formed.DISCUSSION
Our experimental observations and REMD simulations
concur in showing that the N-terminal fragment (residues
1–8) of hIAPP is constrained into a well-defined, rigid struc-
ture containing a type I b-turn. This structure highly favors
the formation of stable interpeptide interactions resulting in
the observed formation of fibers. Cyclization has the effect
of significantly decreasing the conformational entropy cost
Fibers from N-Terminal Loop of Amylin 1667required for fiber formation, making it much more favorable
for the N_loop to aggregate compared to the linear peptide,
N1–8. This mechanism is similar to that exploited in the
design of cyclized, stable b-hairpin peptides that readily
self-assemble into highly ordered nanofibers, rodlike crys-
tals, and other b-sheet aggregates (46–52). To our knowl-
edge, though, this is the first time this mechanism has
been observed for a non-b-sheet fiber, formed by type I
b-turn structures. Molecular simulations suggest that the
amide groups of the N_loop are not correctly aligned for for-
mation of conventional amyloid structure, and simulations
of a pair of N_loops did not reveal any amyloidlike associ-
ation. The rigidity of the N_loop, coupled with the relatively
small number of observed modes of interaction, may explain
the high propensity to form fibrils.
Our observation of stable N_loop fibers at concentrations
as low as 57 mM suggests that the N_loop plays a direct role
in IAPP aggregation. According to structural models of
hIAPP amyloid fibers, these fibers are formed by intermo-
lecular b-sheets involving residues ~25–37 (C-terminal
sheet) and 8 to ~17 (N-terminal sheet), and the N_loop (res-
idues 1–7) is not involved in direct intermolecular interac-
tions (13). However, removal of the N_loop alters both the
mass/length distributions of hIAPP fibers (14) and the
kinetics of fibril formation (15,16). Based on the observed
strong tendency of the N_loop to form interpeptide interac-
tions, we propose that N_loop-N_loop interactions occur-
ring at the N-terminus of full-length IAPP may drive the
initial association of IAPP, before b-sheet formation. This
would be consistent with experimental data on both hIAPP
amyloid fiber formation and the disruption of b-sheet inter-
actions in hIAPP fibers in the presence of rIAPP, as
explained below.
Initial association of IAPP by N_loop-N_loop interac-
tions could occur at a relatively low entropy cost, unlike
the direct association of b-sheets. In sequences that allow
extensive b-sheet formation (e.g., in hIAPP, and not in
rIAPP), such interactions would favor aggregation into
ordered fibrils by aligning the peptides at the N-terminus,
consistent with accepted models of hIAPP fibrils (13).
This mechanism would be consistent with recent 2D-IR
studies indicating that b-sheet structures form in the later
stages of hIAPP aggregation (53), and with p-cyanophenila-
lanine fluorescence studies indicating that side chains of res-
idues 15, 23, and 37 remain partially exposed to solvent
during the lag phase, until significant b-sheet structure has
formed (54). In addition, it would explain the observed
changes in nucleation processes in the absence of the intact
N_loop (15,16). We note that N_loop fibers (i.e., fibers
formed by N_loop-N_loop interactions) have not been
observed so far at equilibrium in full-length hIAPP. Two
factors would interfere with the formation of N_loop-based
fibers in full-length hIAPP: first, intramolecular interactions
between the N_loop and the linear portion of the chain (res-
idues 8–37) will contribute to stabilization of the monomerand compete with N_loop-N_loop interactions. Such intra-
molecular interactions have been proposed by Vaiana
et al. to explain the large degree of compaction observed
in full-length hIAPP and rIAPP, and in a model hydrophilic
sequence that contained the intact N_loop (21). This model
is supported by molecular simulations (21). Second, the dis-
tance between the N_loops in the NMR structures of the
fiber suggest that formation of N_loop-based fibers may
be in competition with the extensive intermolecular
hydrogen bonding of the amyloid fibrils.
Our proposed model would also be consistent with the
ability of rIAPP to disrupt intermolecular b-sheets in hIAPP
amyloid fibers. According to our model, in fact, direct
N_loop-N_loop interactions would also occur in solutions
containing mixtures of IAPP variants. Variants of hIAPP
containing proline substitutions in the C-terminal region,
but with identical N-terminal sequences and intact N_loop
(e.g., rIAPP, I26P, and G24P), have been shown to inhibit
hIAPP amyloid fiber formation, implying a direct interac-
tion between hIAPP and the inhibitor (55,56). Recent results
show that interactions between rIAPP and hIAPP initiate in
the N-terminal region of the peptides and disrupt the native
b-sheet structure of hIAPP amyloid fibers (12). Our present
findings suggest that such interactions could be mediated
by N_loop-N_loop association, which could act in addition
to, or as an alternative to, the originally proposed mecha-
nism of aggregation via a-helical or b-sheet intermediates
(9,19,20,57).
Our proposed role of the N_loop in mediating intermo-
lecular interactions of IAPP may in fact be related to the
role of this highly conserved sequence in the biological
activity of Ct family peptides. Although receptor binding
affinity is mainly determined by residues in the 8–37 region,
the N_loop is required for Ct peptides to activate cell
response when binding to their receptors (58,59), possibly
via interactions between the N_loop and the extramembrane
region of the CGRP receptor (60). We propose that the rigid
type I b-turn structure reported here mediates such interac-
tions. This would be consistent with early work showing
that modifications of the disulfide bridge topography
(by substitution of cysteinyl residues with penicillamine)
can greatly affect CGRP receptor activation upon ligand
binding (61).SUMMARY AND CONCLUSIONS
In conclusion, the data reported here demonstrate for the
first time, to our knowledge, that the N_loop of IAPP forms
stable fibers containing a type I b-turn structure and not
b-sheets. We propose that the rigid b-turn structure plays
a role in both the biological activity of Ct family peptides
and in the pathological aggregation of IAPP, a possibility
that to our knowledge has not yet been explored. We note
that N_loop-N_loop interactions could be exploited to
develop novel inhibitors of hIAPP amyloid formation.Biophysical Journal 105(7) 1661–1669
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